Cliff Asness's IMVT Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 11,082 shares of Immunovant, Inc. (IMVT) worth $426,990, representing 0.00% of the portfolio. First purchased in 2023-Q1, this medium-term investment has been held for 9 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in IMVT, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2023, adding 43,270 shares. Largest reduction occurred in Q3 2024, reducing 76,201 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Immunovant (IMVT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Immunovant (IMVT) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +11,082 | New Buy | 11,082 | $38.53 |
| Q4 2024 | -10,082 | Sold Out | 0 | $0.00 |
| Q3 2024 | -76,201 | Reduce 88.32% | 10,082 | $28.51 |
| Q2 2024 | -2,315 | Reduce 2.61% | 86,283 | $26.40 |
| Q1 2024 | +19,634 | Add 28.47% | 88,598 | $32.31 |
| Q4 2023 | +43,270 | Add 168.41% | 68,964 | $42.13 |
| Q3 2023 | -34,532 | Reduce 57.34% | 25,694 | $38.39 |
| Q2 2023 | +35,501 | Add 143.58% | 60,226 | $18.97 |
| Q1 2023 | +24,725 | New Buy | 24,725 | $15.51 |
Cliff Asness's Immunovant Investment FAQs
Cliff Asness first purchased Immunovant, Inc. (IMVT) in Q1 2023, acquiring 24,725 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Immunovant, Inc. (IMVT) for 9 quarters since Q1 2023.
Cliff Asness's largest addition to Immunovant, Inc. (IMVT) was in Q4 2023, adding 68,964 shares worth $2.91 M.
According to the latest 13F filing for Q2 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 11,082 shares of Immunovant, Inc. (IMVT), valued at approximately $426,990.
As of the Q2 2026 filing, Immunovant, Inc. (IMVT) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Immunovant, Inc. (IMVT) was 88,598 shares, as reported at the end of Q1 2024.